IL10 and Hyperglycemia: Under these conditions, all five recipient mice developed hyperglycemia within 4 weeks after co-infusion of diabetogenic cells (data not shown), indicating that IL-10 secreted by DNCD3 differentiating splenocytes played a critical role to their anti-diabetogenic effect.